114 related articles for article (PubMed ID: 25998804)
1. Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer.
Lund KV; Simonsen TG; Hompland T; Kristensen GB; Rofstad EK
Radiother Oncol; 2015 Jun; 115(3):379-85. PubMed ID: 25998804
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Acta Oncol; 2019 Jun; 58(6):828-837. PubMed ID: 30810443
[No Abstract] [Full Text] [Related]
3. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
[TBL] [Abstract][Full Text] [Related]
4. DCE-MRI-Derived Measures of Tumor Hypoxia and Interstitial Fluid Pressure Predict Outcomes in Cervical Carcinoma.
Simonsen TG; Lund KV; Hompland T; Kristensen GB; Rofstad EK
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1193-1201. PubMed ID: 29859790
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Acta Oncol; 2017 May; 56(5):675-681. PubMed ID: 28447564
[TBL] [Abstract][Full Text] [Related]
6. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e485-92. PubMed ID: 22014954
[TBL] [Abstract][Full Text] [Related]
8. Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy.
Zhang Q; Guo J; Ouyang H; Chen S; Zhao X; Yu X
Eur Radiol; 2022 Apr; 32(4):2529-2539. PubMed ID: 34647177
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Radiother Oncol; 2013 Apr; 107(1):117-22. PubMed ID: 23333024
[TBL] [Abstract][Full Text] [Related]
10. Peritumoral interstitial fluid flow velocity predicts survival in cervical carcinoma.
Hompland T; Lund KV; Ellingsen C; Kristensen GB; Rofstad EK
Radiother Oncol; 2014 Oct; 113(1):132-8. PubMed ID: 25443501
[TBL] [Abstract][Full Text] [Related]
11. Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.
Mayr NA; Huang Z; Wang JZ; Lo SS; Fan JM; Grecula JC; Sammet S; Sammet CL; Jia G; Zhang J; Knopp MV; Yuh WT
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):972-9. PubMed ID: 22208967
[TBL] [Abstract][Full Text] [Related]
12. Cluster analysis of dynamic contrast enhanced MRI reveals tumor subregions related to locoregional relapse for cervical cancer patients.
Torheim T; Groendahl AR; Andersen EK; Lyng H; Malinen E; Kvaal K; Futsaether CM
Acta Oncol; 2016 Nov; 55(11):1294-1298. PubMed ID: 27564398
[TBL] [Abstract][Full Text] [Related]
13. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent.
Narayan K; Fisher RJ; Bernshaw D; Shakher R; Hicks RJ
Int J Gynecol Cancer; 2009 Jul; 19(5):912-8. PubMed ID: 19574784
[TBL] [Abstract][Full Text] [Related]
14. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of nonenhancing tumor fraction assessed by dynamic contrast-enhanced MRI subtraction as a predictor of decrease in tumor volume in response to chemoradiotherapy in advanced cervical cancer.
Mannelli L; Patterson AJ; Zahra M; Priest AN; Graves MJ; Lomas DJ; Tan LT; Crawford R; Brenton J; Sala E
AJR Am J Roentgenol; 2010 Aug; 195(2):524-7. PubMed ID: 20651213
[TBL] [Abstract][Full Text] [Related]
16. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
[TBL] [Abstract][Full Text] [Related]
17. Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors.
Yang W; Qiang JW; Tian HP; Chen B; Wang AJ; Zhao JG
Eur Radiol; 2018 Jan; 28(1):437-445. PubMed ID: 28779395
[TBL] [Abstract][Full Text] [Related]
18. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
[TBL] [Abstract][Full Text] [Related]
19. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
[TBL] [Abstract][Full Text] [Related]
20. Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer.
Kim JY; Byun SJ; Kim YS; Nam JH
Gynecol Oncol; 2017 Jan; 144(1):34-39. PubMed ID: 27789082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
